Mckesson A263 - medications

McKesson Corporation has been awarded a delivery order valued at $11,420.63 by the Federal Correctional Complex Pollock, a civilian facility within the federal corrections system, for the procurement of medications under the MCKESSON A263 contract vehicle. This firm fixed-price delivery order, issued on February 16, 2026, with an ultimate completion date of the same day, represents one of numerous pharmaceutical supply arrangements McKesson maintains across the Bureau of Prisons system. The award carries no small business set-aside designation, reflecting McKesson's established competitive standing as a major healthcare services and pharmaceutical distribution company. Performance will be completed from McKesson's location in Irving, Texas, where the company maintains its corporate headquarters and significant pharmaceutical distribution infrastructure supporting federal agency requirements.

This delivery order exemplifies McKesson's substantial engagement with the Department of Justice's Bureau of Prisons, through which the company serves as a critical pharmaceutical supplier to correctional institutions nationwide. McKesson's federal contract portfolio includes hundreds of delivery orders and purchase orders for controlled and non-controlled medications, specialty pharmaceuticals, and medical consumables supporting Federal Correctional Institutions, Federal Correctional Complexes, United States Penitentiaries, and related facilities. Beyond corrections, McKesson holds significant federal relationships including a $25.5 million Blanket Purchase Agreement with the Department of Homeland Security's Customs and Border Protection for medical and surgical supplies supporting emergency response and pandemic preparedness initiatives, and multiple pharmaceutical supply arrangements with the Indian Health Service under the Department of Health and Human Services.